There are no products in your shopping cart.
| Price: $4.80 |
Description NIACIN (100 MG.) Size: 100 | |
| Health Function: | |
| Brand: | |
| Symptoms: | |
| Nutritional Supplements: |
Niacin (vitamin BB P 3 ) occurs in the body as two metabolically active coenzymes, NAD (nicotinamide adenine dinucleotide) and NADP (NAD phosphate). The niacin coenzymes NAD and NADP have pervasive roles in energy-related and biosynthetic metabolic processes. At least 200 enzymes depend on these niacin cofactors. The NAD-dependent enzymes are involved in mostly catabolic, oxidative reactions that release energy from carbohydrate, fat, and protein, whereas the NADP-dependent enzymes more commonly function in biosynthetic pathways of such compounds as fatty acids and steroid hormones. Independent of its functions as NAD or NADP, niacin is also involved in the regulation of normal blood lipoprotein and cholesterol levels. Dietary niacin is generally well absorbed and taken up by the liver which converts it to NAD and NADP. Any excess niacin is metabolized by the liver and excreted by the kidneys.
Niacin tablets may be a useful nutritional adjunct for individuals who wish to increase their intake of niacin.
7977
One tablet or as directed by physician.
No adverse effects have been reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
Alderman JD et al. Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol 1989;64:725- 729. Canner PL et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986;8:1245-1255. Colletti RB et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993;92:78-82. Keenan JM et al. Niacin revisited: a randomized, controlled trial of wax- matrix sustained-release niacin in hypercholesterolemia. Arch Intern Med 1991;151:1424-1432. Lavie CJ et al. Marked benefit with sustained-release niacin therapy in patients with ‘isolated’ very low levels of high-density lipoprotein cholesterol and coronary artery disease. Am J Cardiol 1992;69:1083- 1085. Probstfield JL. Nicotinic acid as a lipoprotein-altering agent: therapy directed by the primary physician. Arch Int Med 1994;154:1557-1559.
Manufactured by Douglas Laboratories 600 Boyce Road Pittsburgh, PA 15205 800-245-4440 Douglas Laboratories ® Product Data Douglas Laboratories ®
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Shipping Rates
| Order price | Shipping Charge |
| $0 to $21 | $8.95 |
| $21.01 to $50 | $3.85 |
| $50.01 and up | FREE |
![]() |
|||


